2256 related articles for article (PubMed ID: 8881523)
1. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
Ebihara Y; Karmazyn M
Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.
Calderone A; Thaik CM; Takahashi N; Chang DL; Colucci WS
J Clin Invest; 1998 Feb; 101(4):812-8. PubMed ID: 9466976
[TBL] [Abstract][Full Text] [Related]
3. The nitric oxide donors, SNAP and DEA/NO, exert a negative inotropic effect in rat cardiomyocytes which is independent of cyclic GMP elevation.
Sandirasegarane L; Diamond J
J Mol Cell Cardiol; 1999 Apr; 31(4):799-808. PubMed ID: 10329207
[TBL] [Abstract][Full Text] [Related]
4. Modulation of endothelin-1 effects on rat hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
Ebihara Y; Haist JV; Karmazyn M
J Mol Cell Cardiol; 1996 Feb; 28(2):265-77. PubMed ID: 8729059
[TBL] [Abstract][Full Text] [Related]
5. Effect of nitrovasodilators and inhibitors of nitric oxide synthase on ischaemic and reperfusion function of rat isolated hearts.
du Toit EF; McCarthy J; Miyashiro J; Opie LH; Brunner F
Br J Pharmacol; 1998 Mar; 123(6):1159-67. PubMed ID: 9559900
[TBL] [Abstract][Full Text] [Related]
6. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of the positive dromotropic effect of isoproterenol by adenosine: role of nitric oxide, cGMP-dependent cAMP-phosphodiesterase and protein kinase G.
Zima A; Martynyuk AE; Seubert CN; Morey TE; Sumners C; Cucchiara RF; Dennis DM
J Mol Cell Cardiol; 2000 Sep; 32(9):1609-19. PubMed ID: 10966824
[TBL] [Abstract][Full Text] [Related]
8. Contribution of endogenous opioids and nitric oxide to papillary muscle contractile impairment in cholestatic rats.
Ebrahimi F; Tavakoli S; Hajrasouliha AR; Shafaroodi H; Sadeghipour H; Riazi K; Borhani AA; Houshmand G; Ahmadi SH; Dehpour AR
Eur J Pharmacol; 2005 Oct; 523(1-3):93-100. PubMed ID: 16226248
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin-resistant, obese JCR:LA-cp rats.
McKendrick JD; Salas E; Dubé GP; Murat J; Russell JC; Radomski MW
Br J Pharmacol; 1998 May; 124(2):361-9. PubMed ID: 9641554
[TBL] [Abstract][Full Text] [Related]
10. Positive inotropic effect of exogenous and endogenous NO in hypertrophic rat hearts.
Kojda G; Kottenberg K; Stasch JP; Schrör K; Noack E
Br J Pharmacol; 1997 Nov; 122(5):813-20. PubMed ID: 9384495
[TBL] [Abstract][Full Text] [Related]
11. Interaction of nitric oxide and endothelin-1 in ischemia/reperfusion injury of rat heart.
Brunner F
J Mol Cell Cardiol; 1997 Sep; 29(9):2363-74. PubMed ID: 9299360
[TBL] [Abstract][Full Text] [Related]
12. Chronic nitric oxide synthase blockade desensitizes the heart to the negative metabolic effects of nitric oxide.
Davidov T; Weiss HR; Tse J; Scholz PM
Life Sci; 2006 Sep; 79(17):1674-80. PubMed ID: 16831448
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of the nitric oxide-cGMP pathway exacerbates postischaemic heart injury in stroke-prone hypertensive rats.
Itoh T; Haruna M; Abe K
Exp Physiol; 2007 Jan; 92(1):147-59. PubMed ID: 17030559
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of nitric oxide synthase by L-NAME improves ventricular performance in streptozotocin-diabetic rats.
Smith JM; Paulson DJ; Romano FD
J Mol Cell Cardiol; 1997 Sep; 29(9):2393-402. PubMed ID: 9299363
[TBL] [Abstract][Full Text] [Related]
15. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.
Gauthier C; Leblais V; Kobzik L; Trochu JN; Khandoudi N; Bril A; Balligand JL; Le Marec H
J Clin Invest; 1998 Oct; 102(7):1377-84. PubMed ID: 9769330
[TBL] [Abstract][Full Text] [Related]
16. Prolonged effect of a novel S-nitrosated glyco-amino acid in endothelium-denuded rat femoral arteries: potential as a slow release nitric oxide donor drug.
Megson IL; Greig IR; Gray GA; Webb DJ; Butler AR
Br J Pharmacol; 1997 Dec; 122(8):1617-24. PubMed ID: 9422806
[TBL] [Abstract][Full Text] [Related]
17. [Cardioprotective effects of sodium ferulate mediated by nitric oxide on ischemia-reperfusion injured myocardium: experiment with isolated rat hearts].
Liu JC; Kang J; Shao LJ; He M
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):987-91. PubMed ID: 16759542
[TBL] [Abstract][Full Text] [Related]
18. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
[TBL] [Abstract][Full Text] [Related]
19. Involvement of endogenous opioid peptides and nitric oxide in the blunted chronotropic and inotropic responses to beta-adrenergic stimulation in cirrhotic rats.
Ebrahimi F; Tavakoli S; Hajrasouliha AR; Sadeghipour H; Dehghani M; Ahmadi SH; Dehpour AR
Fundam Clin Pharmacol; 2006 Oct; 20(5):461-71. PubMed ID: 16968416
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide regulates the calcium current in isolated human atrial myocytes.
Kirstein M; Rivet-Bastide M; Hatem S; Bénardeau A; Mercadier JJ; Fischmeister R
J Clin Invest; 1995 Feb; 95(2):794-802. PubMed ID: 7860763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
